A new compound, tested so far on rats, shows promise in restoring functions lost by paralysing injury to the spinal cord, a study said on Wednesday. Called intracellular sigma peptide (ISP), the drug helped lab…
A new compound, tested so far on rats, shows promise in restoring functions lost by paralysing injury to the spinal cord, a study said on Wednesday. Called intracellular sigma peptide (ISP), the drug helped lab…